Chris A. Sabillon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chris A. Sabillon has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Chukwuma Egwim
Liver Associates of Texas, USA
1 shared publication - Miriam M. Sanchez
Department of Internal Medicine, Texas Health Resources (HEB/Denton), Bedford, TX 76022, USA
1 shared publication - Stephanie J. Paduano
Department of Internal Medicine, Texas Health Resources (HEB/Denton), Bedford, TX 76022, USA
1 shared publication - Victor Ankoma-Sey
Liver Associates of Texas, Houston, TX 77030, USA
1 shared publication
Latest Publications
- Open Access
- 30 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3112
Frailty, Comorbidities, and In-Hospital Outcomes in Older Cholangiocarcinoma Patients
Introduction: Frailty is increasingly recognized as a critical predictor of adverse outcomes in older adults, particularly those with cancer. However, the role of frailty—distinct from comorbidity burden—has not been fully characterized in older adults hospitalized with cholangiocarcinoma (CCA), a rare but aggressive malignancy with rising incidence in the aging population. Methodology: A retrospective cross-sectional analysis of the Nationwide Inpatient Sample (NIS) 2019–2022 was performed. Adult inpatients aged ≥ 65 with CCA-related ICD-10 codes were identified. Patients were stratified into frailty categories based on the Hospital Frailty Risk Score (HFRS). Multivariable regression models were used to assess associations with in-hospital mortality, length of stay (LOS), and hospital charges. Results: Among 18,785 hospitalizations, the in-hospital mortality rate was 7.18%. High frailty conferred an eight-fold increased risk of mortality, a 70% longer LOS, and 52% higher charges compared to low frailty. Elixhauser comorbidity scores were not significantly associated with outcomes. Discussion: These findings support the use of frailty screening to guide inpatient care planning and optimize outcomes in older adults with CCA.
- 30 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3112
Open AccessFrailty, Comorbidities, and In-Hospital Outcomes in Older Cholangiocarcinoma Patients
Introduction: Frailty is increasingly recognized as a critical predictor of adverse outcomes in older adults, particularly those with cancer. However, the role of frailty—distinct from comorbidity burden—has not been fully characterized in older adults hospitalized with cholangiocarcinoma (CCA), a rare but aggressive malignancy with rising incidence in the aging population. Methodology: A retrospective cross-sectional analysis of the Nationwide Inpatient Sample (NIS) 2019–2022 was performed. Adult inpatients aged ≥ 65 with CCA-related ICD-10 codes were identified. Patients were stratified into frailty categories based on the Hospital Frailty Risk Score (HFRS). Multivariable regression models were used to assess associations with in-hospital mortality, length of stay (LOS), and hospital charges. Results: Among 18,785 hospitalizations, the in-hospital mortality rate was 7.18%. High frailty conferred an eight-fold increased risk of mortality, a 70% longer LOS, and 52% higher charges compared to low frailty. Elixhauser comorbidity scores were not significantly associated with outcomes. Discussion: These findings support the use of frailty screening to guide inpatient care planning and optimize outcomes in older adults with CCA.